Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to $93.6 million.

  • Haemonetics' Cash from Operations rose 11378.24% to $93.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $338.8 million, marking a year-over-year increase of 16215.83%. This contributed to the annual value of $181.7 million for FY2025, which is 1.43% down from last year.
  • As of Q4 2025, Haemonetics' Cash from Operations stood at $93.6 million, which was up 11378.24% from $111.3 million recorded in Q3 2025.
  • Haemonetics' Cash from Operations' 5-year high stood at $116.6 million during Q1 2025, with a 5-year trough of -$27.4 million in Q2 2024.
  • Moreover, its 5-year median value for Cash from Operations was $55.6 million (2022), whereas its average is $51.6 million.
  • The largest annual percentage gain for Haemonetics' Cash from Operations in the last 5 years was 820481.48% (2024), contrasted with its biggest fall of 24367.08% (2024).
  • Quarter analysis of 5 years shows Haemonetics' Cash from Operations stood at $43.5 million in 2021, then skyrocketed by 48.22% to $64.4 million in 2022, then crashed by 100.84% to -$540000.0 in 2023, then soared by 8204.81% to $43.8 million in 2024, then soared by 113.78% to $93.6 million in 2025.
  • Its last three reported values are $93.6 million in Q4 2025, $111.3 million for Q3 2025, and $17.4 million during Q2 2025.